Feature | Artificial Intelligence | March 01, 2019 | By Greg Freiherr

ACC.19 Future Hub Hosts “Shark Tank” of Emerging Technologies In Cardiology

Entrepreneurs to pitch innovative ideas at ACC

ACC Future Hub

Presenter delivers pitch at last year’s ACC Future Hub. This year during ACC.19, entrepreneurs will pitch software and hardware specific to cardiology in two categories– artificial intelligence and digitally enabled medical devices. (Image courtesy of ACC)

Greg Freiherr

Greg Freiherr

Immersed in a Shark Tank-like atmosphere, entrepreneurs will pitch ideas for new technologies and services at ACC.19, this year’s annual meeting of the American College of Cardiology.

The first pitches will be delivered Sunday morning, March 17, beginning at 9:45 am for artificial intelligence (AI) applications in cardiology. A second wave will be tossed the next morning, also at 9:45 am, regarding digitally enabled medical devices. Panels of judges, along with an on-site audience and viewers on Facebook Live, will vote to determine the winner in each category.

The appeal of these challenges will be similar to what attracts viewers to the television show Shark Tank, said AI challenge moderator Andrew M. Freeman, M.D..

“You get people with very pointed and intense questions,” said Freeman, who moderated an “innovation challenge” at last year’s ACC meeting. The director of clinical cardiology at National Jewish Health, an academic hospital/clinic in Denver, compared his duties at this year’s AI challenge to those of a game show host. Primarily, he will try to engage the audience with presenters and keep pitches on schedule.

Freeman was chosen as a moderator, he said, partly for his experience moderating other ACC events, as well as for his passion about medical technology and interest in new ideas to manage cardiac patients. In his practice at National Jewish Health, Freeman integrates evidence-based medicine and plant-based diet, the latter of which has earned him the “Vegan Cardiologist” nickname.

 

Future Hub at ACC19 To Go Beyond Challenges

The challenges in these two categories — AI and digitally enabled devices — will highlight the ACC’s Future Hub, which aims “to inform, educate and inspire ACC.19 attendees by exposing them to the latest innovations in digital health, medical devices and big data,” according to its website. Presentations, including ones on the implications of technology for the doctor-patient relationship, will go on before and after the challenges.

Freeman described ACC’s Future Hub as a unique complement to the scientific sessions going on during the meeting: “I think if anyone is curious about the future of cardiology or medicine, it is certainly a way to get a glimpse of it.”

All Hub presenters will address how emerging technologies might transform cardiovascular practice. Kiosks located in the Future Hub Learning Destination (Expo Hall, #146) will provide individualized hands-on opportunities. The theater in the Hub, where the one-hour challenges will happen, will serve up TED-style talks; small panel discussions and debates on future-based issues; and exhibitor demonstrations.

 

In Search of Angel Investors

To host the challenges, ACC is partnering with AngelMD, self-described as “a healthcare investment community” that combines healthcare startups with physicians, investors, and industry “with the goal of creating successful outcomes.”

The winner of each challenge will be profiled on the AngelMD website. The exposure, Freeman said, could translate into “hundreds of thousands or even millions of dollars” in investments. Winners will also receive kiosk space at next year’s Future Hub; exhibit space at ACC20; and a commemorative plaque.

Last year Challenges featured eight finalists, each with fledgling but promising products or services. They were selected from more than 60 applications assessed by a committee of experts provided by AngelMD. A major criterion for selection was the likelihood of product success.

This year’s two challenges will focus either on AI-based software or digitally enabled hardware. Four finalists in each category will pitch their products or services. They were chosen by a review committee from “dozens of applications,” according to Freeman, who served on the committee.

 

Greg Freiherr is a contributing editor to Imaging Technology News (ITN). Over the past three decades, Freiherr has served as business and technology editor for publications in medical imaging, as well as consulted for vendors, professional organizations, academia, and financial institutions.

 

Editor's note: In preparation for the upcoming American College of Cardiology (ACC) Conference on March 17, contributing editor Greg Freiherr begins the show coverage with this an exclusive series of articles and podcasts. This is the first article in a series of three.

 

Related Content:

Future Hub Showcases Latest Innovations in CV Care; Home to ACC.18 Innovation Challenge 

ACC.19 Innovation Challenge Participants Announced 

 

Related Content

Sponsored Content | Videos | Artificial Intelligence | February 21, 2020
In Artificial Intelligence at RSNA 2019, ITN Contributing Editor Greg Freiherr offers an overview of artificial intel
An example of the MRI scans showing long-term and short-term survival indications. #MRI

An example of the MRI scans showing long-term and short-term survival indications. Image courtesy of Case Western Reserve University

News | Magnetic Resonance Imaging (MRI) | February 21, 2020
February 21, 2020 — ...
An axial CT image obtained without intravenous contrast in a 36‐year‐old male (Panel A) shows bilateral ground‐glass opacities in the upper lobes with a rounded morphology (arrows). #coronavirus #nCoV2019 #2019nCoV #COVID19

An axial CT image obtained without intravenous contrast in a 36‐year‐old male (Panel A) shows bilateral ground‐glass opacities in the upper lobes with a rounded morphology (arrows). Image courtesy of Radiology Online.

News | Computed Tomography (CT) | February 20, 2020
February 20, 2020 — In new research
Two magnetic resonance imaging (MRI) findings — joint capsule edema and thickness at the axillary recess, specifically — proved useful in predicting stiff shoulder in patients with rotator cuff tears, according to an ahead-of-print article in the May issue of the American Journal of Roentgenology (AJR)

A: Oblique coronal fat-suppressed T2-weighted MR image shows normal hypointense joint capsule at axillary recess (arrow). Note full-thickness tear of supraspinatus tendon (arrowheads) B: Oblique sagittal proton density MR image shows preserved subcoracoid fat triangle (asterisk). Image courtesy of the American Journal of Roentgenology (AJR)

News | Magnetic Resonance Imaging (MRI) | February 20, 2020
February 20, 2020 — Two ma...
Chest CT imaging of patient. #coronavirus #nCoV2019 #2019nCoV #COVID19

Examples of typical chest CT findings compatible with COVID-19 pneumonia in patients with epidemiological and clinical presentation suspicious for COVID-19 infection. This image is part of the original research, Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR, published Feb. 19, 2020, in Radiology Online.

News | Computed Tomography (CT) | February 19, 2020
February 19, 2020 — In new research
Sponsored Content | Videos | Enterprise Imaging | February 19, 2020
Bill Lacy, vice president, Medical Informatics at FUJIFILM Medic...
Novel Coronavirus 2019-nCoV Pneumonia. #coronavirus #nCoV2019 #2019nCoV #COVID19

Image by _freakwave_ from Pixabay 

News | Computed Tomography (CT) | February 16, 2020
February 16, 2020 — The following statement was issued by the U.S.
negative RT-PCR results and chest CT findings compatible with 2019-nCoV pneumonia. #coronavirus #nCoV2019 #2019nCoV #COVID19

Figure 1: Patient flowchart. Of 167 patients screened, 5 (3%) had negative RT-PCR results and chest CT findings compatible with 2019-nCoV pneumonia. Chart courtesy of Radiology

Feature | Computed Tomography (CT) | February 14, 2020
As the 2019-nCoV Pneumonia is taking the world by storm, researchers have found a possible way to predict this virus
SIR-Spheres Y-90 resin

SIR-Spheres Y-90 resin microspheres are released into the hepatic artery.

News | Nuclear Imaging | February 14, 2020
February 14, 2020 —  ...